Cargando…

Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses

The peptidylarginine deiminases (PADs) and the citrullinated proteins that they generate have key roles in innate immunity and rheumatoid arthritis, an inflammatory arthritis with antibodies that target citrullinated proteins. However, the importance of PADs, particularly PAD2, in the adaptive immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Mergaert, Aisha M., Denny, Michael F., Kingstad-Bakke, Brock, Bawadekar, Mandar, Bashar, S. Janna, Warner, Thomas F., Suresh, Marulasiddappa, Shelef, Miriam A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786467/
https://www.ncbi.nlm.nih.gov/pubmed/35083342
http://dx.doi.org/10.1155/2022/5258221
_version_ 1784639115892883456
author Mergaert, Aisha M.
Denny, Michael F.
Kingstad-Bakke, Brock
Bawadekar, Mandar
Bashar, S. Janna
Warner, Thomas F.
Suresh, Marulasiddappa
Shelef, Miriam A.
author_facet Mergaert, Aisha M.
Denny, Michael F.
Kingstad-Bakke, Brock
Bawadekar, Mandar
Bashar, S. Janna
Warner, Thomas F.
Suresh, Marulasiddappa
Shelef, Miriam A.
author_sort Mergaert, Aisha M.
collection PubMed
description The peptidylarginine deiminases (PADs) and the citrullinated proteins that they generate have key roles in innate immunity and rheumatoid arthritis, an inflammatory arthritis with antibodies that target citrullinated proteins. However, the importance of PADs, particularly PAD2, in the adaptive immune response, both normal and pathogenic, is newly emerging. In this study, we evaluated a requirement for PAD2 in the antibody response in collagen-induced arthritis (CIA), a T and B cell-driven murine model of rheumatoid arthritis, and in the protective antibody response to murine influenza infection. Using PAD2(−/−) and PAD2(+/+) mice on the DBA/1J background, we found that PAD2 is required for maximal anti-collagen antibody levels, but not collagen-specific plasma cell numbers, T cell activation or polarization, or arthritis severity in CIA. Also, we found that PAD2 is required not just for normal levels of persistent hemagglutination inhibiting antibodies but also for full protection from lethal influenza rechallenge. Together, these data provide evidence for a novel modest requirement for PAD2 in a normal antiviral antibody response and in an abnormal autoantibody response in inflammatory arthritis.
format Online
Article
Text
id pubmed-8786467
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87864672022-01-25 Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses Mergaert, Aisha M. Denny, Michael F. Kingstad-Bakke, Brock Bawadekar, Mandar Bashar, S. Janna Warner, Thomas F. Suresh, Marulasiddappa Shelef, Miriam A. J Immunol Res Research Article The peptidylarginine deiminases (PADs) and the citrullinated proteins that they generate have key roles in innate immunity and rheumatoid arthritis, an inflammatory arthritis with antibodies that target citrullinated proteins. However, the importance of PADs, particularly PAD2, in the adaptive immune response, both normal and pathogenic, is newly emerging. In this study, we evaluated a requirement for PAD2 in the antibody response in collagen-induced arthritis (CIA), a T and B cell-driven murine model of rheumatoid arthritis, and in the protective antibody response to murine influenza infection. Using PAD2(−/−) and PAD2(+/+) mice on the DBA/1J background, we found that PAD2 is required for maximal anti-collagen antibody levels, but not collagen-specific plasma cell numbers, T cell activation or polarization, or arthritis severity in CIA. Also, we found that PAD2 is required not just for normal levels of persistent hemagglutination inhibiting antibodies but also for full protection from lethal influenza rechallenge. Together, these data provide evidence for a novel modest requirement for PAD2 in a normal antiviral antibody response and in an abnormal autoantibody response in inflammatory arthritis. Hindawi 2022-01-17 /pmc/articles/PMC8786467/ /pubmed/35083342 http://dx.doi.org/10.1155/2022/5258221 Text en Copyright © 2022 Aisha M. Mergaert et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mergaert, Aisha M.
Denny, Michael F.
Kingstad-Bakke, Brock
Bawadekar, Mandar
Bashar, S. Janna
Warner, Thomas F.
Suresh, Marulasiddappa
Shelef, Miriam A.
Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses
title Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses
title_full Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses
title_fullStr Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses
title_full_unstemmed Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses
title_short Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses
title_sort peptidylarginine deiminase 2 in murine antiviral and autoimmune antibody responses
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786467/
https://www.ncbi.nlm.nih.gov/pubmed/35083342
http://dx.doi.org/10.1155/2022/5258221
work_keys_str_mv AT mergaertaisham peptidylargininedeiminase2inmurineantiviralandautoimmuneantibodyresponses
AT dennymichaelf peptidylargininedeiminase2inmurineantiviralandautoimmuneantibodyresponses
AT kingstadbakkebrock peptidylargininedeiminase2inmurineantiviralandautoimmuneantibodyresponses
AT bawadekarmandar peptidylargininedeiminase2inmurineantiviralandautoimmuneantibodyresponses
AT basharsjanna peptidylargininedeiminase2inmurineantiviralandautoimmuneantibodyresponses
AT warnerthomasf peptidylargininedeiminase2inmurineantiviralandautoimmuneantibodyresponses
AT sureshmarulasiddappa peptidylargininedeiminase2inmurineantiviralandautoimmuneantibodyresponses
AT shelefmiriama peptidylargininedeiminase2inmurineantiviralandautoimmuneantibodyresponses